CEO Jacob Thaysen and CFO Ankur Dhingra will host a conference call at 1:30 pm Pacific Time (4:30 pm Eastern Time) the same day to unpack the results. The company invites analysts and shareholders to participate via a live webcast available through the investor relations portal on its website. Participants are encouraged to log in at least ten minutes early to avoid potential connection delays.
In section Releases
Illumina Sets Date for Third Quarter 2026 Financial Results
San Diego-based genomics giant Illumina, Inc. will report its financial performance for the third quarter of 2026 on Thursday, October 29. The release follows the close of market trading, marking a critical update for investors monitoring the company’s recent trajectory in DNA sequencing and array-based technologies.
A recording of the discussion will remain accessible on the company’s site for 30 days following the event. Illumina maintains a dominant position in the clinical and research markets, providing tools that facilitate breakthroughs in oncology, reproductive health, and agricultural science.
Comments (0)
No comments yet. Be the first!